Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fufang Weite'an is a Traditional Chinese Medicine (TCM) compound formulation developed as a hospital preparation by the Affiliated Hospital of Changchun University of Traditional Chinese Medicine. It is specifically indicated for the treatment of epigastric pain and chronic superficial gastritis. The formulation is designed to tonify the spleen, harmonize the stomach, and alleviate pain, addressing the underlying TCM syndromes associated with chronic gastric distress. As a hospital-specific medication (yiyuan zhiji), it is manufactured and dispensed within the developing institution's pharmacy system for clinical use in managing gastric mucosal inflammation and related symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fufang Weite'an.